These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33936038)

  • 1. Establishing a Risk Prediction Model for Atherosclerosis in Systemic Lupus Erythematosus.
    Xing H; Pang H; Du T; Yang X; Zhang J; Li M; Zhang S
    Front Immunol; 2021; 12():622216. PubMed ID: 33936038
    [No Abstract]   [Full Text] [Related]  

  • 2. Early Clinical Features in Systemic Lupus Erythematosus: Can They Be Used to Achieve Earlier Diagnosis? A Risk Prediction Model.
    Rees F; Doherty M; Lanyon P; Davenport G; Riley RD; Zhang W; Grainge MJ
    Arthritis Care Res (Hoboken); 2017 Jun; 69(6):833-841. PubMed ID: 27588834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of MTHFR gene variants in lupus related subclinical atherosclerosis.
    Giannelou M; Nezos A; Fragkioudaki S; Kasara D; Maselou K; Drakoulis N; Ioakeimidis D; Moutsopoulos HM; Mavragani CP
    Clin Immunol; 2018 Aug; 193():110-117. PubMed ID: 29501539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
    Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
    Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
    Fischer K
    Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-seq of circular RNAs identified circPTPN22 as a potential new activity indicator in systemic lupus erythematosus.
    Miao Q; Zhong Z; Jiang Z; Lin Y; Ni B; Yang W; Tang J
    Lupus; 2019 Apr; 28(4):520-528. PubMed ID: 30871426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary micronutrient intake and atherosclerosis in systemic lupus erythematosus.
    Lourdudoss C; Elkan AC; Hafström I; Jogestrand T; Gustafsson T; van Vollenhoven R; Frostegård J
    Lupus; 2016 Dec; 25(14):1602-1609. PubMed ID: 27334936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nighttime Blood Pressure Patterns and Subclinical Atherosclerosis in Women with Systemic Lupus Erythematosus.
    Sabio JM; Martinez-Bordonado J; Sánchez-Berná I; Vargas-Hitos JA; Mediavilla JD; Navarrete-Navarrete N; Zamora-Pasadas M; Ruíz ME; Jiménez-Alonso J
    J Rheumatol; 2015 Dec; 42(12):2310-7. PubMed ID: 26568596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Mok CC; Poon WL; Lai JP; Wong CK; Chiu SM; Wong CK; Lun SW; Ko GT; Lam CW; Lam CS
    Scand J Rheumatol; 2010; 39(1):42-9. PubMed ID: 20132070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of carotid atherosclerosis in systemic lupus erythematosus.
    Maksimowicz-McKinnon K; Magder LS; Petri M
    J Rheumatol; 2006 Dec; 33(12):2458-63. PubMed ID: 17014002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyzing the pathogenesis of systemic lupus erythematosus complicated by atherosclerosis using transcriptome data.
    Wang Y; Su W; Li Y; Yuan J; Yao M; Su X; Wang Y
    Front Immunol; 2022; 13():935545. PubMed ID: 35935949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus.
    Urowitz MB; Gladman D; Ibañez D; Bae SC; Sanchez-Guerrero J; Gordon C; Clarke A; Bernatsky S; Fortin PR; Hanly JG; Wallace DJ; Isenberg D; Rahman A; Alarcón GS; Merrill JT; Ginzler E; Khamashta M; Nived O; Sturfelt G; Bruce IN; Steinsson K; Manzi S; Ramsey-Goldman R; Dooley MA; Zoma A; Kalunian K; Ramos M; Van Vollenhoven RF; Aranow C; Stoll T; Petri M; Maddison P;
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):881-7. PubMed ID: 20535799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
    J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
    Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E
    PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell activating factor and related genetic variants in lupus related atherosclerosis.
    Theodorou E; Nezos A; Antypa E; Ioakeimidis D; Koutsilieris M; Tektonidou M; Moutsopoulos HM; Mavragani CP
    J Autoimmun; 2018 Aug; 92():87-92. PubMed ID: 29859654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease trends over time and CD4
    Baragetti A; Ramirez GA; Magnoni M; Garlaschelli K; Grigore L; Berteotti M; Scotti I; Bozzolo E; Berti A; Camici PG; Catapano AL; Manfredi AA; Ammirati E; Norata GD
    Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):53-63. PubMed ID: 29150407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of subclinical atherosclerosis by serum osteoprotegerin in premenopausal women with systemic lupus erythematous: correlation of osteoprotegerin with monocyte chemotactic protein-1.
    Park YJ; Shin YJ; Kim WU; Cho CS
    Lupus; 2014 Mar; 23(3):236-44. PubMed ID: 24531425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype.
    Ahmad Y; Shelmerdine J; Bodill H; Lunt M; Pattrick MG; Teh LS; Bernstein RM; Walker MG; Bruce IN
    Rheumatology (Oxford); 2007 Jun; 46(6):983-8. PubMed ID: 17384179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting three-year kidney graft survival in recipients with systemic lupus erythematosus.
    Tang H; Poynton MR; Hurdle JF; Baird BC; Koford JK; Goldfarb-Rumyantzev AS
    ASAIO J; 2011; 57(4):300-9. PubMed ID: 21701272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the Risk of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: A Chinese Systemic Lupus Erythematosus Treatment and Research Group Cohort Study.
    Qu J; Li M; Wang Y; Duan X; Luo H; Zhao C; Zhan F; Wu Z; Li H; Yang M; Xu J; Wei W; Wu L; Liu Y; You H; Qian J; Yang X; Huang C; Zhao J; Wang Q; Leng X; Tian X; Zhao Y; Zeng X
    Arthritis Rheumatol; 2021 Oct; 73(10):1847-1855. PubMed ID: 34105259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.